Category: Pharmaceuticals and Biotech

Crossing the Blood-Brain Barrier - the Human Element of Abuse Potential Assessment, New Webinar Hosted by Xtalks
Press Release -

Crossing the Blood-Brain Barrier - the Human Element of Abuse Potential Assessment, New Webinar Hosted by Xtalks

CNS drug developers have to focus on physical safety and efficacy first, especially when developing products for rare disorders or diagnoses that are often unresponsive to other therapies. Although these products rarely have notable CNS mediated side effects, they fall under the FDA's requirement for an abuse potential assessment because they cross the blood-brain barrier.

The Highs and Lows of Cannabinoid Research: Exploring the Regulatory, Clinical, and Bioanalytical Requirements in US and Canada, New Webinar Hosted by Xtalks
Press Release -

The Highs and Lows of Cannabinoid Research: Exploring the Regulatory, Clinical, and Bioanalytical Requirements in US and Canada, New Webinar Hosted by Xtalks

Interest in the medical use of cannabis and cannabinoids continues to grow as patients and caregivers consider this option for treatment of unmet medical needs. Ever growing efforts to legalize cannabinoids in the US and Canada are creating an increased need to evaluate safe and effective use.

Increasing Hip and Knee Replacement Surgeries is Driving the Global Antithrombotic Drugs Market to Grow at 6.83% of CAGR by 2026
Press Release -

Increasing Hip and Knee Replacement Surgeries is Driving the Global Antithrombotic Drugs Market to Grow at 6.83% of CAGR by 2026

According to the new market research report launched by Inkwood Research, The Global Antithrombotic Drugs market was valued at nearly $24900 million in 2017 and is anticipated to reach $45100 million by 2026, growing at an estimated CAGR of 6.83%, during the forecast period 2018-2026.

Biologics R&D Data Management: Why Labs Aren't Reaching Their Full Potential & Best Practices to Course Correct, New Webinar Hosted by Xtalks
Press Release -

Biologics R&D Data Management: Why Labs Aren't Reaching Their Full Potential & Best Practices to Course Correct, New Webinar Hosted by Xtalks

At the heart of key challenges facing biologics laboratories today lies the volume and complexity of data created throughout the scientific process

Firalis Launches BIOPRED to Better Target Inflammatory Autoimmune Diseases
Press Release -

Firalis Launches BIOPRED to Better Target Inflammatory Autoimmune Diseases

FIRALIS S.A. announces the launch of the Biopred panel, an innovative RUO product that profiles thousands of mRNAs associated with inflammatory autoimmune disorders via a pioneering targeted mRNA profiling technology without RNA extraction.

VMS BioMarketing Launches New Corporate Website
Press Release -

VMS BioMarketing Launches New Corporate Website

New website provides practical solutions to challenges of medication adherence

Nobilis Therapeutics Adds Three World-Renowned PTSD Experts to Scientific Advisory Board
Press Release -

Nobilis Therapeutics Adds Three World-Renowned PTSD Experts to Scientific Advisory Board

Nobilis Therapeutics, today announced addition of Dr. Paula Schnurr, Dr. Barbara Rothbaum and Dr. Israel Liberzon to its Scientific Advisory Board.

Spiders, Swimmers, & More - Critical Oncology Data Insights (Part 2), Upcoming June 2018 Webinar Series Hosted by Xtalks
Press Release -

Spiders, Swimmers, & More - Critical Oncology Data Insights (Part 2), Upcoming June 2018 Webinar Series Hosted by Xtalks

Second of 2-part Series to Examine Spider and Dosing Plots

ClinOne Named a Top 25 Life Sciences Technology Vendor by CIO Applications Magazine
Press Release -

ClinOne Named a Top 25 Life Sciences Technology Vendor by CIO Applications Magazine

Featured as cover story in May 2018 issue